Patents by Inventor Zhong Zhao

Zhong Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230281448
    Abstract: This application provides a method for information recommendation performed by an electronic device.
    Type: Application
    Filed: May 11, 2023
    Publication date: September 7, 2023
    Inventors: Li MA, Zhong ZHAO, Hanming LIANG, Guangyao ZHAO, Yanmei FU, Weibo HU, Xinsheng HE, Mingjin WU
  • Publication number: 20220305169
    Abstract: The present disclosure belongs to the technical field of hemostatic materials, and specifically relates to a degradable hemostatic sponge and a preparation method and use thereof, and a degradable drug-loaded hemostatic sponge. The degradable hemostatic sponge provided by the present disclosure is prepared from raw materials including a crosslinking-modified starch and a cellulose through freeze-drying, where a mass ratio of the crosslinking-modified starch to the cellulose is (0.2-5):1. The degradable hemostatic sponge provided by the present disclosure has a high water-absorbing rate and a large water-absorbing capacity, shows a high support strength and a long support time after water absorption, and is made from plant-derived raw materials and thus may be completely biodegraded. The degradable drug-loaded starch hemostatic sponge provided by the present disclosure has a drug-loaded coating attached to a surface of the sponge, where the drug is slowly released while a support is maintained.
    Type: Application
    Filed: July 8, 2021
    Publication date: September 29, 2022
    Inventors: Peipei CAO, Jonathon Zhong ZHAO, Guanya WU
  • Publication number: 20220073508
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
    Type: Application
    Filed: April 14, 2021
    Publication date: March 10, 2022
    Applicant: Genzyme Corporation
    Inventors: Elyse BOURQUE, Mario A. CABRERA-SALAZAR, Cassandra CELATKA, Seng H. CHENG, Bradford HIRTH, Andrew GOOD, Katherine JANCSICS, John MARSHALL, Markus METZ, Ronald K. SCHEULE, Renato SKERLJ, Yibin XIANG, Zhong ZHAO, John LEONARD, Thomas NATOLI, Elina MAKINO, Herve HUSSON, Oxana BESKROVNAYA
  • Patent number: 11209267
    Abstract: An apparatus to detect the topology of a workpiece including surface variations and flaws according to images from several viewpoints includes a frame, a loading member, a robot, an image capturing mechanism, and a controller. The loading member is positioned on the frame and loads a workpiece. The controller controls the robot to drive the image capturing mechanism to move or rotate to different preset positions from each of which the image capturing mechanism can capture images of the workpiece and transmit the images to the controller. The controller further processes the images to obtain an assessment of the components and surface of the workpiece for further processing.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: December 28, 2021
    Assignee: HONGFUJIN PRECISION ELECTRONICS(TIANJIN)CO., LTD.
    Inventor: Qiao-Zhong Zhao
  • Publication number: 20210261557
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: April 27, 2021
    Publication date: August 26, 2021
    Applicant: GENZYME CORPORATION
    Inventors: Elyse BOURQUE, Mario CABRERA-SALAZAR, Cassandra CELATKA, Seng CHENG, Mary A. CROMWELL, Andrew GOOD, Bradford HIRTH, Katherine JANCSICS, John P. LEONARD, Lingyun LI, James LILLIE, Hanlan LIU, Elina MAKINO, John MARSHALL, Paul MASON, Markus METZ, Fazeela MORSHED, Thomas O'SHEA, Ronald SCHEULE, Renato SKERLJ, Bing WANG, Yibin XIANG, Zhong ZHAO
  • Patent number: 11008316
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS), such as Compound of Formula I, shown below, as defined herein, useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: May 18, 2021
    Assignee: GENZYME CORPORATION
    Inventors: Elyse Bourque, Mario A. Cabrera-Salazar, Cassandra Celatka, Seng H. Cheng, Bradford Hirth, Andrew Good, Katherine Jancsics, John Marshall, Markus Metz, Ronald K. Scheule, Renato Skerlj, Yibin Xiang, Zhong Zhao, John Leonard, Thomas Natoli, Elina Makino, Herve Husson, Oxana Beskrovnaya
  • Publication number: 20200225279
    Abstract: A smart decision feedback method for inspecting a circuit board includes obtaining a number of abnormal solder paste points of a circuit board identified by a solder paste inspection device, determining whether the number of abnormal solder paste points is greater than or equal to a first predetermined value, determining whether an identification result of the solder paste inspection device is abnormal when the number of abnormal solder paste points is less than the first predetermined value, obtaining an inspection result performed by a testing device inspecting the circuit board when the identification result of the solder paste inspection device is abnormal, analyzing an adjustment parameter of the solder paste inspection device, and sending the adjustment parameter to the solder paste inspection device. A first prompt is displayed when the number of abnormal solder paste points is greater than or equal to the first predetermined value.
    Type: Application
    Filed: January 29, 2019
    Publication date: July 16, 2020
    Inventors: QIAO-ZHONG ZHAO, SHIH-LIN WU
  • Publication number: 20200090319
    Abstract: A machine learning method is used for improving accuracy of an automated optical inspection (AOI) device. The method includes obtaining an image of a component to be inspected, processing the image to generate digital image information, establishing a machine learning model according to the digital image information, inputting the digital image information into the machine learning model for determination, verifying accuracy of a result of determination by the machine learning model, adjusting and optimizing the machine learning model according to the result of determination of the accuracy of the machine learning model, and improving the machine learning model until the machine learning model reaches a predetermined accuracy.
    Type: Application
    Filed: January 24, 2019
    Publication date: March 19, 2020
    Inventors: MING-KUEI LIAO, QIAO-ZHONG ZHAO, YI-TING LIU
  • Publication number: 20200049495
    Abstract: An apparatus to detect the topology of a workpiece including surface variations and flaws according to images from several viewpoints includes a frame, a loading member, a robot, an image capturing mechanism, and a controller. The loading member is positioned on the frame and loads a workpiece. The controller controls the robot to drive the image capturing mechanism to move or rotate to different preset positions from each of which the image capturing mechanism can capture images of the workpiece and transmit the images to the controller. The controller further processes the images to obtain an assessment of the components and surface of the workpiece for further processing.
    Type: Application
    Filed: June 27, 2019
    Publication date: February 13, 2020
    Inventor: QIAO-ZHONG ZHAO
  • Publication number: 20200048266
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 13, 2020
    Inventors: Elyse BOURQUE, Mario CABRERA-SALAZAR, Cassandra CELATKA, Seng CHENG, Mary A. CROMWELL, Andrew GOOD, Bradford HIRTH, Katherine JANCSICS, John P. LEONARD, Lingyun LI, James LILLIE, Hanlan LIU, Elina MAKINO, John MARSHALL, Paul MASON, Markus METZ, Fazeela MORSHED, Thomas O'SHEA, Ronald SCHEULE, Renato SKERLJ, Bing WANG, Yibin XIANG, Zhong ZHAO
  • Publication number: 20180312525
    Abstract: The invention features compounds of Formula (I), Formula (I)-A and Formula (I)-B as disclosed herein, as well as methods of synthesis, therapy, diagnostics, and assays.
    Type: Application
    Filed: July 3, 2018
    Publication date: November 1, 2018
    Inventors: Paul Mason, Kara Carter, Alexandra Joseph, Yiding Hu, Jill Gregory, Zhong Zhao, Christopher Yee, Mohamud Mohamud, Yibin Xiang, Sanjay Danthi, Yinyin Huang, Andrew Papoulis
  • Patent number: 10017523
    Abstract: The invention features compounds of Formula (I), Formula (I)-A and Formula (I)-B as disclosed herein, as well as methods of synthesis, therapy, diagnostics, and assays.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: July 10, 2018
    Assignee: Genzyme Corporation
    Inventors: Paul Mason, Kara Carter, Alexandra Joseph, Yiding Hu, Jill Gregory, Zhong Zhao, Christopher Yee, Mohamud Mohamud, Yibin Xiang, Sanjay Danthi, Yinyin Huang, Andrew Papoulis
  • Publication number: 20180065957
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
    Type: Application
    Filed: April 18, 2017
    Publication date: March 8, 2018
    Applicant: Genzyme Corporation
    Inventors: Elyse BOURQUE, Mario A. CABRERA-SALAZAR, Cassandra CELATKA, Seng H. CHENG, Bradford Hirth, Andrew GOOD, Katherine JANCSICS, John MARSHALL, Markus Metz, Ronald K. SCHEULE, Renato SKERLJ, Yibin XIANG, Zhong ZHAO, John LEONARD, Thomas NATOLI, Elina MAKINO, Herve HUSSON, Oxana BESKROVNAYA
  • Patent number: 9808830
    Abstract: An ultrasound transducer and an ultrasound imaging system including an acoustic layer with a plurality of transducer elements and a dematching layer coupled to the acoustic layer. The dematching layer has an acoustic impedance greater than the acoustic layer and the dematching layer has a thickness that varies in order to alter a bandwidth of the ultrasound probe.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: November 7, 2017
    Assignee: GENERAL ELECTRIC COMPANY
    Inventors: Alan Tai, Frederic Lanteri, Scott Easterbrook, Jian Zhong Zhao
  • Publication number: 20170107231
    Abstract: The invention features compounds of Formula (I), Formula (I)-A and Formula (I)-B as disclosed herein, as well as methods of synthesis, therapy, diagnostics, and assays.
    Type: Application
    Filed: May 22, 2015
    Publication date: April 20, 2017
    Inventors: Paul Mason, Kara Carter, Alexandra Joseph, Yiding Hu, Jill Gregory, Zhong Zhao, Christopher Yee, Mohamud Mohamud, Yibin Xiang, Sanjay Danthi, Yinyin Huang, Andrew Papoulis
  • Publication number: 20160207933
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: August 25, 2015
    Publication date: July 21, 2016
    Inventors: Elyse BOURQUE, Mario CABRERA-SALAZAR, Cassandra CELATKA, Seng CHENG, Mary A. CROMWELL, Andrew GOOD, Bradford HIRTH, Katherine JANCSICS, John P. LEONARD, Lingyun LI, James LILLIE, Hanlan LIU, Elina MAKINO, John MARSHALL, Paul MASON, Markus METZ, Fazeela MORSHED, Thomas O'SHEA, Ronald SCHEULE, Renato SKERLJ, Bing WANG, Yibin XIANG, Zhong ZHAO
  • Publication number: 20150210681
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
    Type: Application
    Filed: September 10, 2013
    Publication date: July 30, 2015
    Applicant: GENZYME CORPORATION
    Inventors: Elyse Bourque, Mario A. Cabrera-Salazar, Cassandra Celatka, Seng H. Cheng, Bradford Hirth, Andrew Good, Katherine Jancsics, John Marshall, Markus Metz, Ronald K. Scheule, Renato Skerlj, Yibin Xiang, Zhong Zhao, John Leonard, Thomas Natoli, Elina Makino, Herve Husson, Oxana Beskrovnaya
  • Publication number: 20150183000
    Abstract: An ultrasound transducer and an ultrasound imaging system including an acoustic layer with a plurality of transducer elements and a dematching layer coupled to the acoustic layer. The dematching layer has an acoustic impedance greater than the acoustic layer and the dematching layer has a thickness that varies in order to alter a bandwidth of the ultrasound probe.
    Type: Application
    Filed: February 19, 2015
    Publication date: July 2, 2015
    Inventors: Alan Tai, Frederic Lanteri, Scott Easterbrook, Jian Zhong Zhao
  • Publication number: 20140371460
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: August 28, 2014
    Publication date: December 18, 2014
    Inventors: Elyse BOURQUE, Cassandra CELATKA, Bradford HIRTH, Markus METZ, Zhong ZHAO, Renato SKLERJ, Yibin XIANG, Katherine JANCSICS, John MARSHALL, Seng CHENG, Ronald SCHEULE, Mario CABRERA-SALAZAR, Andrew GOOD
  • Publication number: 20140255381
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: September 18, 2013
    Publication date: September 11, 2014
    Applicant: GENZYME CORPORATION
    Inventors: Elyse BOURQUE, Cassandra CELATKA, Bradford HIRTH, Markus METZ, Zhong ZHAO, Renato SKLERJ, Yibin XIANG, Katherine JANCSICS, John MARSHALL, Seng CHENG, Ronald SCHEULE, Mario CABRERA-SALAZAR, Andrew GOOD